发明名称 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
摘要 Method of identifying compounds that modulate intermolecular interactions between a target protein and a modifier are disclosed. Pharmaceutical composition comprising compounds that inhibit intermolecular interactions between a target protein and a modifier are disclosed. Methods of treating individual suffering from inflammatory conditions, undesirable immune responses, immunological conditions and bacterial infections are disclosed.
申请公布号 US8785419(B2) 申请公布日期 2014.07.22
申请号 US201113194832 申请日期 2011.07.29
申请人 The Trustees Of The University Of Pennsylvania 发明人 Murali Ramachandran;Greene Mark I.
分类号 A01N33/26;A61K31/655;A01N43/36;A61K31/40;A01N37/28;A61K31/215;A01N47/28;A61K31/17;A61K8/42 主分类号 A01N33/26
代理机构 Baker & Hostetler LLP 代理人 Baker & Hostetler LLP
主权项 1. A method of inhibiting CD4-mediated signaling in a subject comprising administering to said subject an effective amount of a compound of Formula (IV), (V), or (VI), or a pharmaceutically acceptable salt thereof.
地址 Philadelphia PA US